MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. INNV
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

InnovAge Holding (INNV) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

InnovAge Holding
NasdaqGS•Healthcare•Medical Care Facilities
$10.75-0.02(<0.01%)Market closed
Market Cap
$1.43B
P/S
1.5x
P/B
6.1x

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. It serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 1989 and is headquartered in Denver, Colorado.

B

How this company scores

GoodMetricSide Score: 63/100

Strongest: Growth (19/25); weakest: Cash & Earnings Quality (14/25).

Profitability14/25
Growth19/25
Balance Sheet & Red Flags16/25
Cash & Earnings Quality14/25
Strengths
Rising free cash flowLong cash runwayLow leverageProfit converts from growth

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 110.2x5y range 110.2x – 110.2x
P/E 110.2x
P/S · 1.5x5y range 0.5x – 1.5x
P/S 1.5x · above its 18-quarter median

Currently above its 18-quarter median.

P/B · 6.1x5y range 1.5x – 7.2x
P/B 6.1x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

FCF consistently trails net income (avg -1.2x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume
Market Cap $1.43B

Metrics at a Glance

as of March 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue
$949.17M
7Q
Q. Revenue
$251.94M
7Q
TTM EBITDA
$8.50M
177%
TTM Op. Income
$-9.68M
70%
Q. Op. Income
$-29.08M
186%
TTM Net Income
$-11.61M
63%
Q. Net Income
$-29.46M
159%
EPS
$-0.22
175%
Shares Out.
$135.70M
3Q
$949.17M in TTM revenue grew 14.1% YoY, reaching $251.94M last quarter. TTM EBITDA of $8.50M and TTM operating income of $-9.68M show growth is flowing through to the bottom line. However, net income is negative at $11.61M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin
24.2%
3Q
EBITDA Margin
-9.6%
340%
Op. Margin
-11.5%
148%
Net Margin
-11.7%
124%
Op. margin of -11.5% is down 6.9% YoY — costs are rising relative to revenue. Net margin at -11.7% and gross margin of 24.2% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 148% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio
N/A
P/S Ratio
1.5x
4Q
P/B Ratio
6.1x
4Q
P/S of 1.5x and P/B of 6.1x. P/S is low relative to typical market levels.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets
$547.39M
2Q
Cash
$95.54M
6Q
Long-Term Debt
$55.43M
3Q
Book Value
$232.78M
5%
D/E Ratio
0.2
3214%
Debt/EBITDA
N/A
4Q
With $547.39M in assets and $55.43M in long-term debt, D/E is 0.2and book value is $232.78M — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is up 3214% — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$18.14M
26%
TTM Free Cash Flow
$42.56M
166%
FCF Margin
4.5%
133%
FCF / Net Income
-3.7
616%
TTM FCF of $42.56M on $18.14M in operating cash flow. The FCF / Net Income ratio of -3.7x means the business consumes cash — it is not yet self-funding. Over the past year, free cash flow is up 166% — a weakening trend.

Related Stocks in Healthcare

View Sector
LLY$938.28B
Lilly (Eli)
Drug Manufacturers - General
JNJ$586.47B
Johnson & Johnson
Drug Manufacturers - General
ABBV$411.57B
AbbVie
Drug Manufacturers - General
MRK$303.29B
Merck & Co.
Drug Manufacturers - General
UNH$249.74B
UnitedHealth Group
Healthcare Plans
TMO$203.77B
Thermo Fisher Scientific
Diagnostics & Research
AMGN$201.34B
Amgen
Drug Manufacturers - General
GILD$191.61B
Gilead Sciences
Drug Manufacturers - General
· above its 20-quarter median

Currently above its 20-quarter median.

Leverage Risk

Watch

Debt-to-equity has risen 3213.7% recently — increasing financial risk even if the current ratio is manageable.

Cash Burn

Watch

FCF turned negative in 3 of the last 8 quarters — occasional cash consumption.